Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages 1381-1386

  Walker, Gary V ^a   Niikura, Naoki ^b   Yang, Wei ^a   Rohren, Eric ^a   Valero, Vicente ^a   Woodward, Wendy A ^a   Alvarez, Ricardo H ^a   Lucci Jr , Anthony ^a   Ueno, Naoto T ^a   Buchholz, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chest wall radiation therapy; Inflammatory breast cancer; Positron emission tomography

Indexed keywords

BREAST CANCER; BREAST MRI; CHEST CT; CHEST RADIOGRAPHY; CHEST WALL; DISTANT METASTASIS; DOSE PRESCRIPTION; FIELD DESIGN; INFORMATION CONCERNING; LIVER IMAGING; LYMPH NODE; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; PRE-TREATMENT; RADIATION TREATMENTS; RADIOTHERAPY TREATMENT; RETROSPECTIVE ANALYSIS; SECOND PRIMARY TUMORS; TARGET VOLUMES; ULTRASONOGRAPHIC EXAMINATION;

BODY FLUIDS; BONE; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; DISEASES; PATIENT MONITORING; POSITRONS; RADIOTHERAPY;

POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; IMAGING SYSTEM; INFLAMMATORY BREAST CANCER; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREMEDICATION; PRIORITY JOURNAL; RADIATION DOSE; THORAX RADIOGRAPHY; THORAX WALL; TREATMENT PLANNING;

ADULT; AGED; AXILLA; BREAST; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATORY BREAST NEOPLASMS; LYMPH NODES; LYMPHATIC IRRADIATION; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; POSTOPERATIVE CARE; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RESIDUAL VOLUME; RETROSPECTIVE STUDIES;

EID: 84863629136     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.040     Document Type: Article

References (19)

1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Breast cancer, v.2.2011. Available at: http://www.nccn.org/ professionals/physician-gls/PDF/breast.pdf (free access but log in required) Accessed 7/14/2011.
2. I.J. Bristol, W.A. Woodward, and E.A. Strom Locoregional treatment outcomes after multimodality management of inflammatory breast cancer Int J Radiat Oncol Biol Phys 72 2 2008 474 484
3. K.W. Hance, W.F. Anderson, S.S. Devesa, H.A. Young, and P.H. Levine Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute J Natl Cancer Inst 97 13 2005 966 975
4. R.L. Wahl, B.A. Siegel, R.E. Coleman, C.G. Gatsonis, and PET Study Group Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the staging breast cancer with PET Study Group J Clin Oncol 22 2 2004 277 285
5. D. Fuster, J. Duch, and P. Paredes Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures J Clin Oncol 26 29 2008 4746 4751
6. N. Niikura, C.M. Costelloe, and J.E. Madewell FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer Oncologist 16 8 2011 1111 1119
7. S.B. Edge, D.R. Byrd, and C.C. Compton AJCC Cancer Staging Manual 7th ed 2009 Springer New York
8. N. Niikura, J. Liu, and C.M. Costelloe Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer Oncologist 16 6 2011 772 782
9. I.J. Bristol, and T.A. Buchholz Inflammatory breast cancer: Current concepts in local management Breast Dis 22 2005-2006 75 83
10. I.J. Bristol, W.A. Woodward, and E.A. Strom Locoregional treatment outcomes after multimodality management of inflammatory breast cancer Int J Radiat Oncol Biol Phys 72 2 2008 474 484
11. J.J. van der Hoeven, N.C. Krak, and O.S. Hoekstra 18F-2-Fluoro-2-deoxy-d- glucose positron emission tomography in staging of locally advanced breast cancer J Clin Oncol 22 7 2004 1253 1259
12. J. Tseng, L.K. Dunnwald, and E.K. Schubert 18F-FDG kinetics in locally advanced breast cancer: Correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy J Nucl Med 45 11 2004 1829 1837
13. M. Schelling, N. Avril, and J. Nahrig Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J Clin Oncol 18 8 2000 1689 1695
14. I.C. Smith, A.E. Welch, and A.W. Hutcheon Positron emission tomography using [(18)F]-fluorodeoxy-d-glucose to predict the pathologic response of breast cancer to primary chemotherapy J Clin Oncol 18 8 2000 1676 1688
15. W.T. Yang, H.T. Le-Petross, and H. Macapinlac Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings Breast Cancer Res Treat 109 3 2008 417 426
16. S. Carkaci, H.A. Macapinlac, and M. Cristofanilli Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: Preliminary data J Nucl Med 50 2 2009 231 238
17. J.L. Alberini, F. Lerebours, and M. Wartski 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer Cancer 115 21 2009 5038 5047
18. D. Groheux, J.L. Moretti, and G. Baillet Effect of (18)F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer Int J Radiat Oncol Biol Phys 71 3 2008 695 704
19. S.J. Rosenbaum, T. Lind, G. Antoch, and A. Bockisch False-positive FDG PET uptake: The role of PET/CT Eur Radiol 16 5 2006 1054 1065